SEC Form 4 · accession 0001638599-17-000178
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fuentes Luis Gerardo Gutierrez
Director
Period of report
Feb 8, 2017
Accepted (ET)
Feb 10, 2017 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 8, 2017 | A | 3,802 | $0.00 | A | 6,656 | D | |
| Common StockF1 | holding | — | — | — | 2,200,000 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2 | $18.41 | Feb 8, 2017 | A | 9,358 | A | — | Feb 8, 2027 | Common Stock | 9,358 | 9,358 | D |
Explanation of responses
- F1These shares are held directly by 3-Gutinver, S.L., a company organized and existing under the laws of Spain. The Reporting Person is the Sole Administrator of 3-Gutinver, S.L. and may be deemed to beneficially hold these securities in such capacity. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed and admission that the Reporting Person is the beneficial owner of such securities for the purposes of Section 16 or any other purpose.
- F2Option is exercisable as to 1/3rd of the shares annually on the anniversary date of the grant for each of the next three years.